Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of community-acquired pneumonia and pneumonia-related hospitalizations in children ≤5 years after its implementation into the national immunization program of Turkey

References

• Rudan I, O’Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, Lukšić I, Fischer Walker CL, Black RE, Campbell H. Child Health Epidemiology Reference Group (CHERG). Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3(1):010401. doi:10.7189/jogh.03.010401.
   PubMed Web of Science ®Google Scholar
• Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, Thomson A. British thoracic society standards of care committee British thoracic society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(Suppl 2):ii1. doi:10.1136/thoraxjnl-2011-200598.
   PubMedGoogle Scholar
• Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, Albertson SB, Deshpande A, Farag T, Abebe Z. GBD 2016 lower respiratory infections collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1191–210. doi:10.1016/S1473-3099(18)30310-4.
   PubMed Web of Science ®Google Scholar
• Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, et al. CDC EPIC study team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–45. doi:10.1056/NEJMoa1405870.
   PubMed Web of Science ®Google Scholar
• Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9(1):109. doi:10.1111/j.1440-1843.2003.00522.x.
   PubMed Web of Science ®Google Scholar
• Kurz H, Göpfrich H, Wabnegger L, Apfalter P. Role of Chlamydophila pneumoniae in children hospitalized for community-acquired pneumonia in Vienna, Austria. Pediatr Pulmonol. 2009;44(9):873. doi:10.1002/ppul.21059.
   PubMed Web of Science ®Google Scholar
• Skinner JM, Indrawati L, Cannon J, Blue J, Winters M, Macnair J, Pujar N, Manger W, Zhang Y, Antonello J, et al. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15- CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine. 2011;29:8870–76. doi:10.1016/j.vaccine.2011.09.078.
   PubMed Web of Science ®Google Scholar
• Ceyhan M. Konjuge Pnömokok Aşılarında Son Gelişmeler: 13-Valanlı Konjuge Pnömokok Aşısı. J Pediatr Inf. 2011;5:68–73. doi:10.5152/ced.2011.25.
   Google Scholar
• WHO World Health Organization. Immunization summary http://apps.who.int/gho/data/node.main.PCV3n?lang=en.
   Google Scholar
• Berglund A, Ekelund M, Fletcher MA, Nyman L. All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction. PLoS One. 2014;9(11):e112211. doi:10.1371/journal.pone.0112211.
   PubMed Web of Science ®Google Scholar
• Lindstrand A, Bennet R, Galanis I, Blennow M, Ask LS, Dennison SH, Rinder MR, Eriksson M, Henriques-Normark B, Örtqvist Å, et al. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics. 2014;134(6):e1528–e1536. doi:10.1542/peds.2013-4177.
   PubMed Web of Science ®Google Scholar
• Fitzwater SP, Chandran A, Santosham M, Johnson HL. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2012;31(5):501–08. doi:10.1097/INF.0b013e31824de9f6.
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;369(9568):1179–86. doi:10.1016/S0140-6736(07)60564-9.
   PubMed Web of Science ®Google Scholar
• Cohen R, Cohen JF, Chalumeau M, Levy C. Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries. Expert Rev Vaccines. 2017;16(6):625–40. doi:10.1080/14760584.2017.1320221.
   PubMed Web of Science ®Google Scholar
• Hansen J, Black S, Shinefield H, Cherian T, Benson J, Fireman B, Lewis E, Ray P, Lee J. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using world health organization standardized interpretation of chest radiographs. Pediatr Infect Dis J. 2006;25:779–81. doi:10.1097/01.inf.0000232706.35674.2f.
   PubMed Web of Science ®Google Scholar
• Wiese AD, Griffin MR, Grijalva CG. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States. Expert Rev Vaccines. 2019 Apr;18(4):327–41. doi:10.1080/14760584.2019.1582337.
   PubMed Web of Science ®Google Scholar
• Elemraid MA, Rushton SP, Shirley MD, Thomas MF, Spencer DA, Eastham KM, Hampton F, Gorton R, Pollard K, Gennery AR, et al. North East of England paediatric respiratory infection study group. Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia. Epidemiol Infect. 2013 Aug;141(8):1697–704. doi:10.1017/S0950268812002257.
   PubMedGoogle Scholar
• Thorrington D, Andrews N, Stowe J, Miller E, van Hoek AJ. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control. BMC Med. 2018 8;16(1):13. doi:10.1186/s12916-018-1004-z.
   PubMed Web of Science ®Google Scholar
• Naucler P, Henriques-Normark B, Hedlund J, Galanis I, Granath F, Örtqvist Å. The changing epidemiology of community-acquired pneumonia: nationwide register-based study in Sweden. J Intern Med. 2019 Jul 6;286:689–701. doi:10.1111/joim.12956. [ Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Durando P, Crovari P, Ansaldi F, Sticchi L, Sticchi C, Turello V, Marensi L, Giacchino R, Timitilli A, Carloni R, et al. Collaborative group for pneumococcal vaccination in Liguria. Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. Vaccine. 2009;27(25–26):3459–62. doi:10.1016/j.vaccine.2009.01.052.
   PubMed Web of Science ®Google Scholar
• Azzari C, Serranti D, Nieddu F, Moriondo M, Casini A, Lodi L, de Benedictis FM, De Vitis E, Cavone F, Cortimiglia M, et al. Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: italy 2006–2018. Vaccine. 2019;37(20):2704–11. doi:10.1016/j.vaccine.2019.04.012.
   PubMed Web of Science ®Google Scholar
• van Deursen AMM, Schurink-Van’t Klooster TM, Man WH, van de Kassteele J, van Gageldonk-lafeber AB, Bruijning-Verhagen PCJL, de Melker HE, Sanders EAM, Knol MJ. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands. Vaccine. 2017;35(51):7107–13. doi:10.1016/j.vaccine.2017.10.090.
   PubMed Web of Science ®Google Scholar
• Greenberg D, Givon-Lavi N, Ben-Shimol S, Ziv JB, Dagan R. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years. vaccine. 2015;33(36):4623–29. doi:10.1016/j.vaccine.2015.06.062.
   PubMed Web of Science ®Google Scholar
• Ouldali N, Levy C, Minodier P, Morin L, Biscardi S, Aurel M, Dubos F, Dommergues MA, Mezgueldi E, Levieux K, et al. Long-term association of 13-valent pneumococcal conjugate vaccine implementation with rates of community-acquired pneumonia in children. JAMA Pediatr. 2019;173(4):362–70. doi:10.1001/jamapediatrics.2018.5273.
   PubMed Web of Science ®Google Scholar
• Soysal A, Karabağ-Yılmaz E, Kepenekli E, Karaaslan A, Cagan E, Atıcı S, Atınkanat-Gelmez G, Boran P, Merdan S, Hasdemir U, et al. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey. Vaccine. 2016;34:3894–900. doi:10.1016/j.vaccine.2016.05.043.
   PubMed Web of Science ®Google Scholar